Google has recently unveiled a set of new tools designed to help businesses strengthen their first-party data strategy. These tools, called Tag Diagnostics and a new Consent Management Setup, are now available in Google Ads, Google Analytics, and Google Tag Manager. Here’s what you need to know about them.

Tag diagnostics: Keeping your measurement setup healthy

Tag Diagnostics is a new feature that provides notifications about potential issues in your measurement setup and guidance on how to fix them. Whether it’s a missing Google Tag on your site or a conversion linker tag needed to connect your ad data to conversion actions, Tag Diagnostics gives you an at-a-glance view of your account health. This ensures you can quickly address any issues that might impact your measurement capabilities. With this tool, Google is making it easier than ever to view and manage your measurement readiness in one place, helping you better build and activate your first-party data.

Streamlined consent management setup

In addition to Tag Diagnostics, Google is rolling out a streamlined Consent Management Setup. This new solution integrates seamlessly with many of Google’s CMP (Consent Management Platform) partners, simplifying the deployment of consent banners and consent mode. The integrated CMP setup allows you to create and implement consent banners directly within the Google Tag Manager interface with just a few clicks, reducing friction and complexity.

The new CMP setup offers:

• In-product guidance: Tailored instructions to help you navigate your specific setup.
• CMP integration: Easy connection with a variety of CMP providers, including Cookiebot by Usercentrics, iubenda, and Usercentrics.
• Simplified banner installation: A hassle-free way to implement your chosen banner, either manually or directly within Google Tag Manager.

These new tools are rolling out to all accounts globally, with Tag Diagnostics available now and the Consent Management Setup being gradually introduced over the next few weeks.

Find more details here.